Beyond the Pain: Unveiling the Quality of Life Impairment in Prolanis Patients With Joint Pain Through the SF-36 Lens

Yanuar Murna Isti'fart

Abstract

Chronic joint pain is a debilitating condition often experienced by individuals with comorbid chronic diseases such as diabetes and hypertension, severely impairing their quality of life (QoL). In rural Indonesia, where access to rehabilitative care is limited, understanding the impact of joint pain is critical for improving patient outcomes. This study explores the effect of joint pain on QoL among Prolanis participants using the SF-36 Health Survey. Conducted at Puskesmas Purwantoro 2, Wonogiri, Central Java, in August 2025, the research identifies that joint pain significantly affects physical functioning, pain, and general health, with strong correlations to metabolic control (HbA1c) and renal function (eGFR). While physical health is notably impaired, psychosocial aspects, such as emotional well-being and social functioning, remain relatively unaffected, suggesting a potential buffer effect from the Prolanis community support. The findings highlight the need for a holistic approach to chronic disease management, addressing both physical pain and strategies for improving metabolic and renal health. This study provides valuable insights for developing interventions that could improve the lives of those dealing with chronic joint pain, guiding future healthcare strategies in managing complex chronic diseases.

Keywords: Quality of life, joint pain, SF-36, Prolanis, chronic disease

Keywords

Quality of life; joint pain; SF-36; Prolanis; chronic disease

Full Text:

PDF

References

“Panduan Program Pengelolaan Penyakit Kronis,” BPJS Kesehatan, 2020.

N. Black, “Patient reported outcome measures could help transform healthcare,” BMJ, p. 346, 2021.

E. K. Maulana, I., Nuryunarsih, E., & Dewi, “Validity and reliability test of Indonesian version SF-36 questionnaire for assessing quality of life in diabetes mellitus patients,” J. Ilmu Keperawatan, vol. 5, no. 2, pp. 105–112, 2021.

et al Zhang, W., Moskowitz, R. W., Nuki, G., “OARSI recommendations for the management of hip and knee osteoarthritis: Part II,” Osteoarthr. Cartil., vol. 16, no. 2, pp. 137–162, 2021.

M. Fuggle, N. R., Cooper, C., Oreffo, R. O., Price, A. J., & Javaid, “The pathogenesis of osteoarthritis: Risk factors and mechanisms,” Nat. Rev. Rheumatol., vol. 16, no. 12, pp. 622–634, 2020.

R. C. Mathew, R. O., Bangalore, S., Lavelle, M. P., & Bansal, “Chronic kidney disease and quality of life: Current perspectives,” Int. J. Nephrol. Renovasc. Dis., vol. 12, pp. 101–112, 2021.

E. Hunter, D. J., Schofield, D., & Callander, “The individual and socioeconomic impact of osteoarthritis,” Nat. Rev. Rheumatol., vol. 10, no. 7, pp. 437–441, 2021.

et al Peeters, M. J., van Zuilen, A. D., van den Brand, J. A., “Health-related quality of life in chronic kidney disease: A comparison between dialysis patients and non-dialysis patients,” Nephrol. Dial. Transplant., vol. 28, no. 1, pp. 187–193, 2021.

M. P. Gallant, “The influence of social support on chronic illness self-management: A review and directions for research,” Heal. Educ. Behav., vol. 30, no. 2, pp. 170–195, 2021.

DOI: https://doi.org/10.20961/tscm.v3i3.110049

Refbacks

  • There are currently no refbacks.